
Sign up to save your podcasts
Or
Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.
TPM E47 highlights >
Episode 47 links:
4.7
77 ratings
Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.
TPM E47 highlights >
Episode 47 links:
418 Listeners
43,440 Listeners
9,284 Listeners
110,845 Listeners
316 Listeners
61 Listeners
5,418 Listeners
9,243 Listeners
30 Listeners
1,161 Listeners